title: Establishing comparable requirements and treatment groups before applying statistical comparison-reply.
authors.affiliation: Division of Cardiology, St Lukes-Roosevelt Hospital, Mount Sinai Health System, New York, New York.
authors.forename: Saurav
authors.initials: S
authors.lastname: Chatterjee
authors.affiliation: Department of Medicine, New York Medical College-Metropolitan Hospital Center, New York, New York.
authors.forename: Partha
authors.initials: P
authors.lastname: Sardar
authors.affiliation: Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Biondi-Zoccai
authors.affiliation: Division of Cardiology, University of Texas Southwestern, Dallas, Texas.
authors.forename: Dharam J
authors.initials: DJ
authors.lastname: Kumbhani
mesh_terms: D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D020300:Intracranial Hemorrhages / Q000139:chemically induced*
chemical_list: D000925:Anticoagulants